Medications for osteoporotic pain

DOI QR Code

Shin, Sang Wook (Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine)

Mattia C, Coluzzi F, Celidonio L, Vellucci R. Bone pain mechanism in osteoporosis: a narrative review. Clin Cases Miner Bone Metab 2016; 13: 97-100.
Lee YJ, Park CH, Lee YK, Ha YC, Koo KH. Which bisphosphonate? It's the compliance!: decision analysis. J Bone Metab 2016; 23: 79-83. https://doi.org/10.11005/jbm.2016.23.2.79
Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 2014; 25: 2359-81. https://doi.org/10.1007/s00198-014-2794-2
Kim SY, Ok HG, Birkenmaier C, Kim KH. Can denosumab be a substitute, competitor, or compliment to bisphosphonates? Korean J Pain 2017; 30: 86-92. https://doi.org/10.3344/kjp.2017.30.2.86
Tetsunaga T, Tetsunaga T, Nishida K, Tanaka M, Sugimoto Y, Takigawa T, et al. Denosumab and alendronate treatment in patients with back pain due to fresh osteoporotic vertebral fractures. J Orthop Sci 2017; 22: 230-6. https://doi.org/10.1016/j.jos.2016.11.017